XI’AN, China, May 22, 2025 (GLOBE NEWSWIRE) — Bon Natural Life Limited (Nasdaq: BON)...
XI’AN, China, May 22, 2025 (GLOBE NEWSWIRE) — Bon Natural Life Limited (Nasdaq: BON)...
Roth, G. A. et al. Global burden of cardiovascular diseases and...
More than a quarter of women in England are living with a serious reproductive health issue,...
FILSPARI holds strong market potential as the first FDA-approved non-immunosuppressive therapy for IgA nephropathy, a rare kidney...